FR2275214A1 - Procede de production de preparations de cephalosporine - Google Patents

Procede de production de preparations de cephalosporine

Info

Publication number
FR2275214A1
FR2275214A1 FR7325666A FR7325666A FR2275214A1 FR 2275214 A1 FR2275214 A1 FR 2275214A1 FR 7325666 A FR7325666 A FR 7325666A FR 7325666 A FR7325666 A FR 7325666A FR 2275214 A1 FR2275214 A1 FR 2275214A1
Authority
FR
France
Prior art keywords
oxyethylene
poly
cephalosporin
suppositories
ethers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7325666A
Other languages
English (en)
Other versions
FR2275214B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2275214A1 publication Critical patent/FR2275214A1/fr
Application granted granted Critical
Publication of FR2275214B1 publication Critical patent/FR2275214B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7325666A 1972-07-14 1973-07-12 Procede de production de preparations de cephalosporine Granted FR2275214A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7116372A JPS4930519A (fr) 1972-07-14 1972-07-14

Publications (2)

Publication Number Publication Date
FR2275214A1 true FR2275214A1 (fr) 1976-01-16
FR2275214B1 FR2275214B1 (fr) 1978-07-28

Family

ID=13452681

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7325666A Granted FR2275214A1 (fr) 1972-07-14 1973-07-12 Procede de production de preparations de cephalosporine

Country Status (3)

Country Link
JP (1) JPS4930519A (fr)
ES (1) ES416907A1 (fr)
FR (1) FR2275214A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033241A2 (fr) * 1980-01-25 1981-08-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques pour administration rectale
EP0091502A1 (fr) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha Composition pharmaceutique de céphalosporine pour administration rectale

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5336520B2 (fr) * 1972-03-16 1978-10-03
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS55119771U (fr) * 1979-01-23 1980-08-25

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033241A2 (fr) * 1980-01-25 1981-08-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques pour administration rectale
EP0033241A3 (fr) * 1980-01-25 1982-04-21 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques pour administration rectale
EP0091502A1 (fr) * 1982-04-13 1983-10-19 Asahi Kasei Kogyo Kabushiki Kaisha Composition pharmaceutique de céphalosporine pour administration rectale

Also Published As

Publication number Publication date
JPS4930519A (fr) 1974-03-19
FR2275214B1 (fr) 1978-07-28
ES416907A1 (es) 1976-03-16

Similar Documents

Publication Publication Date Title
ES417405A1 (es) Procedimiento para la preparacion de espumas de colorante solidas.
FR2275214A1 (fr) Procede de production de preparations de cephalosporine
ES427963A1 (es) Procedimiento para la preparacion de derivados de 5-metil-7-hidroxi-isoflavona.
GB1203083A (en) A method for producing bearings
GB1369604A (en) Reduction of intermodulation products in amplifiers
CA981185A (en) Regenerative repeater output stage for bipolar coded message signals
CA969558A (en) Manufacture of polyalkylene ethers
ES412341A1 (es) Un metodo para producir una preparacion farmaceutica de un compuesto de penicilina para uso rectal.
CA995686A (en) 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of polyalkylene glycols and compositions stabilized thereby
JPS5338690A (en) Isolation of co-enzyme q
FR2257268A1 (en) Collection and storage of bone marrow - under non oxidising conditions to prevent deterioration
ES417985A1 (es) Procedimiento de preparacion de compuestos sicianosil-quer-cetina.
CA946818A (en) Derivatives of glycols, clycol ethers and glycol esters
AU4088872A (en) Trialkylsilyl ethers of 11-alkyl-17-alkynylestra-1, 3, 5(10)-trien-3, 17-diols
GB1374949A (en) Stable low current amplifier
GB1375410A (fr)
CA625891A (en) Copolymer of a polyalkylene ether glycol, an organic di-isocyanate and a polyhydroxy compound
FR2230384A1 (en) Fire-extinguisher compsn. contg. protein foaming agent - and glycol or glycol monoalkyl ether, giving better foam properties
CA806705A (en) Preparation of di-p-carboxy phenyl ether of ethylene glycol
AU452527B2 (en) Ejector aerated oxidation ditch for waste treatment
GB1515674A (en) Bleaching assistant suitable for use in washing and bleaching agents and a process for its preparation
CA962673A (en) ACYLOXYMETHYL ESTERS OF .alpha.-UREIDOPHENYL ALKYLENE PENICILLINS
GB826397A (en) Improvements in or relating to electrical contacts
CA894767A (en) Treatment of polyphenyl ethers
CA827135A (en) Method of preparing new biologically active low water-soluble compounds of bacitracin